Get the Stockscreener App
353.75
0.12%
-0.43
After Hours:
353.75
United Therapeutics Corp Stock (UTHR) Latest News
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial - The Business Journals
State Street Corp Reduces Stake in United Therapeutics Corp - GuruFocus.com
UTHRUnited Therapeutics Corp Latest Stock News & Market Updates - StockTitan
United Therapeutics president sells $3.5m in stock - MSN
United Therapeutics president sells $3.5m in stock By Investing.com - Investing.com Australia
FDA approves pig organ transplant trials for patients with kidney failure - The Washington Post
United Therapeutics Corporation's (NASDAQ:UTHR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
US FDA greenlights clinical trails for pig kidney transplants in humans - MSN
Breakthrough IPF Treatment Study Hits Key Milestone: 598 Patients Enrolled in Game-Changing Tyvaso Trial - StockTitan
US approves trials for pig kidney transplants in humans - NewsBytes
Short Interest in United Therapeutics Co. (NASDAQ:UTHR) Decreases By 14.3% - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Stock Holdings Raised by Janney Montgomery Scott LLC - MarketBeat
United Therapeutics (NASDAQ:UTHR) Stock Price Down 4.9%Here's What Happened - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat
FDA approves United Therapeutics' xeno-organ trial - Investing.com
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial - United Therapeutics Corporation
Revolutionary Pig-to-Human Kidney Transplant Trial Gets Historic FDA Green Light - StockTitan
United Therapeutics Co. (NASDAQ:UTHR) Position Reduced by New England Research & Management Inc. - MarketBeat
Robeco Institutional Asset Management B.V. Sells 4,094 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Swedbank AB Sells 79,432 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
KBC Group NV Acquires 7,169 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
SG Americas Securities LLC Has $1.15 Million Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) COO Sells $3,707,100.00 in Stock - MarketBeat
Manchester gets offer from United Therapeutics to buy nearly 350 acres in Hackett Hill area - AOL
United Therapeutics president sells shares worth $3.7 million By Investing.com - Investing.com South Africa
United Therapeutics president sells shares worth $3.7 million - MSN
Pacer Advisors Inc. Buys 30,931 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Nepsis Inc. Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Veracity Capital LLC Purchases 1,446 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Nisa Investment Advisors LLC Boosts Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
HB Wealth Management LLC Purchases Shares of 1,066 United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
United Therapeutics plans $96M facility for genetically edited swine in northeast Houston - The Business Journals
United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN
United Therapeutics president Michael Benkowitz sells shares worth $3.65m By Investing.com - Investing.com Canada
Merit Financial Group LLC Has $1.22 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by Park Avenue Securities LLC - Defense World
0.53%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):